Paper39239653
Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology.
Li XL and 4 others. Front Pharmacol, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology. Papers, record 39239653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39239653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alkaloids in Chelidonium majus L: a review of its phytochemistry, pharmacology and toxicology.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26969379 | Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells. | Phytomedicine | 2016 | https://conductscience.org/library/papers/26969379 | PubMed |
| 2 | 14615066 | Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. | Toxicol Lett | 2003 | https://conductscience.org/library/papers/14615066 | PubMed |
| 3 | 19183517 | Antibacterial alkaloids from chelidonium majus linn (papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus. | J Pharm Pharm Sci | 2008 | https://conductscience.org/library/papers/19183517 | PubMed |
| 4 | 37566135 | 6-Methoxydihydrosanguinarine exhibits cytotoxicity and sensitizes TRAIL-induced apoptosis of hepatocellular carcinoma cells through ROS-mediated upregulation of DR5. | Med Oncol | 2023 | https://conductscience.org/library/papers/37566135 | PubMed |
| 5 | 17077538 | 8-hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine with a potent acetylcholinesterase inhibitory activity from Chelidonium majus L. | Biol Pharm Bull | 2006 | https://conductscience.org/library/papers/17077538 | PubMed |
| 6 | 10232064 | Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. | Planta Med | 1999 | https://conductscience.org/library/papers/10232064 | PubMed |
| 7 | 31629049 | New lignanamides and alkaloids from Chelidonium majus and their anti-inflammation activity. | Fitoterapia | 2019 | https://conductscience.org/library/papers/31629049 | PubMed |
| 8 | 34201532 | Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34201532 | PubMed |
| 9 | 38367423 | Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38367423 | PubMed |
| 10 | 38820341 | A Hidden Cause of Hypertransaminasemia: Liver Toxicity Caused by Chelidonium Majus L. : Report of Two Cases of Herb-Induced Liver Injury and Literature Review. | Am J Ther | 2024 | https://conductscience.org/library/papers/38820341 | PubMed |
| 11 | 36139911 | Chelerythrine-Induced Apoptotic Cell Death in HepG2 Cells Involves the Inhibition of Akt Pathway and the Activation of Oxidative Stress and Mitochondrial Apoptotic Pathway. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36139911 | PubMed |
| 12 | 34585628 | Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19. | Cell Cycle | 2021 | https://conductscience.org/library/papers/34585628 | PubMed |
| 13 | 32912124 | A Review on Classification and Biological Activities of Alkaloids from the Genus Zanthoxylum Species. | Mini Rev Med Chem | 2021 | https://conductscience.org/library/papers/32912124 | PubMed |
| 14 | 17226510 | (+)-Norchelidonine from Chelidonium majus. | Planta Med | 1992 | https://conductscience.org/library/papers/17226510 | PubMed |
| 15 | 21739961 | Biocatalytic organic synthesis of optically pure (S)-scoulerine and berbine and benzylisoquinoline alkaloids. | J Org Chem | 2011 | https://conductscience.org/library/papers/21739961 | PubMed |
| 16 | 32284120 | In vitro antifungal activity and possible mechanisms of action of chelerythrine. | Pestic Biochem Physiol | 2020 | https://conductscience.org/library/papers/32284120 | PubMed |
| 17 | 29713277 | Greater Celandine's Ups and Downs-21 Centuries of Medicinal Uses of Chelidonium majus From the Viewpoint of Today's Pharmacology. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/29713277 | PubMed |
| 18 | 29571014 | Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29571014 | PubMed |
| 19 | 31443589 | Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell Lines. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/31443589 | PubMed |
| 21 | 21665451 | Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia. | Phytomedicine | 2011 | https://conductscience.org/library/papers/21665451 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42643345 | Potential of isoquinoline-alkaloid-rich Papaveraceae extracts against bacteria causing ocular infections - In vitro and In vivo study. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42643345 | PubMed |
| 42122881 | Medicinal Plants for Dermatological and Cosmetic Applications: Ethnobotanical Study from Northern Lithuania. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42122881 | PubMed |
| 41774285 | Therapeutic effects of Chelidonium majus on ocular surface ınflammation and tear film homeostasis in a benzalkonium chloride-ınduced rat model of dry eye disease. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/41774285 | PubMed |
| 41683628 | Chelidonine Induces Concurrent Elevation of pSer-STAT3 and Bcl-2 Levels in a Mitotic Subpopulation of Human T-Leukemia/Lymphoma Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683628 | PubMed |
| 41600130 | Current Knowledge and Utilization of Medicinal Plants and Fungi in Northeastern Croatia. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/41600130 | PubMed |
| 41472003 | Antifungal Effects and Mechanism of Dihydrochelerythrine Against Fusarium oxysporum. | Microorganisms | 2025 | https://conductscience.org/library/papers/41472003 | PubMed |
| 41226667 | Impact of Isoquinoline Alkaloids on the Intestinal Barrier in a Colonic Model of Campylobacter jejuni Infection. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226667 | PubMed |
| 40941792 | Chelidonium majus L.: A Current Perspective on Isoquinoline Alkaloids, Emerging Phytochemicals, Alkaloid Biosynthesis, and Biological Activities. | Plants (Basel) | 2025 | https://conductscience.org/library/papers/40941792 | PubMed |
| 39598801 | The Synergistic Mechanism of Chelidonium majus Alkaloids on Melanoma Treatment via a Multi-Strategy Insight. | Molecules | 2024 | https://conductscience.org/library/papers/39598801 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39239653
GET https://conductscience.org/api/papers/v1/39239653/references?page=2